HACE1 could act as a tumor suppressor in various human malignancies, including lung cancer [29], HCC [30], breast cancer [31], osteosarcoma [32], colorectal cancer [33], gastric cancer [34], Leukemia [35] and Wilms tumors [36]. This evidence concerns the gene HACE1 and breast carcinoma.